FIORILLO, ANNARITA
FIORILLO, ANNARITA
Phenotypical and biochemical characterization of tomato plants treated with triacontanol
2024 Manai, M.; Fiorillo, A.; Matuozzo, M.; Li, M.; D'Ambrosio, C.; Franco, L.; Scaloni, A.; Fogliano, V.; Camoni, L.; Marra, M.
Innovative Approach for a Classic Target: Fragment Screening on Trypanothione Reductase Reveals New Opportunities for Drug Design
2022 Fiorillo A.; Colotti G.; Exertier C.; Liuzzi A.; Seghetti F.; Salerno A.; Caciolla J.; Ilari A.
Optimization of Potent and Specific Trypanothione Reductase Inhibitors: A Structure-Based Drug Discovery Approach
2022 Battista, T; Federico, S; Brogi, S; Pozzetti, L; Khan, T; Butini, S; Ramunno, A; Fiorentino, E; Orsini, S; Di Muccio, T; Fiorillo, A; Exertier, C; Di Risola, D; Colotti, G; Gemma, S; Ilari, A; Campiani, G
Huntingtin Ubiquitination Mechanisms and Novel Possible Therapies to Decrease the Toxic Effects of Mutated Huntingtin
2021 Annarita Fiorillo; Veronica Morea; Gianni Colotti; Andrea Ilari
Structure and metal-binding properties of PA4063, a novel player in periplasmic zinc trafficking by Pseudomonas aeruginosa
2021 Fiorillo, Annarita; Battistoni, Andrea; Ammendola, Serena; Secli, Valerio; Rinaldo, Serena; Cutruzzola, Francesca; Demitri, Nicola; Ilari, Andrea
The phosphoglycerate kinase 1 variants found in carcinoma cells display different catalytic activity and conformational stability compared to the native enzyme
2018 Fiorillo A.; Petrosino M.; Ilari A.; Pasquo A.; Cipollone A.; Maggi M.; Chiaraluce R.; Consalvi V.
Toward a Drug Against All Kinetoplastids: From LeishBox to Specific and Potent Trypanothione Reductase Inhibitors
2018 Ilari A.; Genovese I.; Fiorillo F.; Battista T.; De Ionna I.; Fiorillo A.; Colotti G.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Phenotypical and biochemical characterization of tomato plants treated with triacontanol | 1-gen-2024 | Manai, M.; Fiorillo, A.; Matuozzo, M.; Li, M.; D'Ambrosio, C.; Franco, L.; Scaloni, A.; Fogliano, V.; Camoni, L.; Marra, M. | |
| Innovative Approach for a Classic Target: Fragment Screening on Trypanothione Reductase Reveals New Opportunities for Drug Design | 1-gen-2022 | Fiorillo A.; Colotti G.; Exertier C.; Liuzzi A.; Seghetti F.; Salerno A.; Caciolla J.; Ilari A. | |
| Optimization of Potent and Specific Trypanothione Reductase Inhibitors: A Structure-Based Drug Discovery Approach | 1-gen-2022 | Battista, T; Federico, S; Brogi, S; Pozzetti, L; Khan, T; Butini, S; Ramunno, A; Fiorentino, E; Orsini, S; Di Muccio, T; Fiorillo, A; Exertier, C; Di Risola, D; Colotti, G; Gemma, S; Ilari, A; Campiani, G | |
| Huntingtin Ubiquitination Mechanisms and Novel Possible Therapies to Decrease the Toxic Effects of Mutated Huntingtin | 1-gen-2021 | Annarita Fiorillo; Veronica Morea; Gianni Colotti; Andrea Ilari | |
| Structure and metal-binding properties of PA4063, a novel player in periplasmic zinc trafficking by Pseudomonas aeruginosa | 1-gen-2021 | Fiorillo, Annarita; Battistoni, Andrea; Ammendola, Serena; Secli, Valerio; Rinaldo, Serena; Cutruzzola, Francesca; Demitri, Nicola; Ilari, Andrea | |
| The phosphoglycerate kinase 1 variants found in carcinoma cells display different catalytic activity and conformational stability compared to the native enzyme | 1-gen-2018 | Fiorillo A.; Petrosino M.; Ilari A.; Pasquo A.; Cipollone A.; Maggi M.; Chiaraluce R.; Consalvi V. | |
| Toward a Drug Against All Kinetoplastids: From LeishBox to Specific and Potent Trypanothione Reductase Inhibitors | 1-gen-2018 | Ilari A.; Genovese I.; Fiorillo F.; Battista T.; De Ionna I.; Fiorillo A.; Colotti G. |